Speaker illustration

Doctor Guilherme Pessoa Amorim

University of Oxford, Oxford (United Kingdom of Great Britain & Northern Ireland)

I am a NIHR Oxford Biomedical Research Centre Clinical Research Fellow, based at the Clinical Trial Service Unit (CTSU). Here, I am working under the joint supervision of Professor Barbara Casadei and Professor Louise Bowman in the AMALFI (Active Monitoring for AtriaL FIbrilation) trial, a study which aims to shed light on the burden of subclinical atrial fibrillation in elderly high-risk patients. I am also part of the clinical team for the ORION-4 (A Randomized Trial Assessing the Effects of Inclisiran on Clinical Outcomes Among People With Cardiovascular Disease) trial, a study which is assessing the effect of inclisiran, a novel cholesterol-lowering therapy, on cardiovascular events on patients with established atherosclerotic disease. My research interests include atrial fibrillation, heart failure and cardiovascular imaging, as well as randomised controlled trials and big data approaches to studying cardiovascular disease.

An invasive strategy is associated with improved short- and long-term outcomes in acute myocardial infarction independently of frailty status and GRACE score: a nationwide analysis of 12144 episodes

Event: ESC Congress 2020

Topic: Cardiovascular Disease in the Elderly

Session: Cardiovascular Disease in the Elderly


Reverse left atrial functional remodeling after surgical aortic valve replacement is dependent on impaired left atrial function and reverse left ventricular remodeling

Event: EuroEcho 2019

Topic: Tissue Doppler, Speckle Tracking and Strain Imaging

Session: Tissue Doppler, Speckle Tracking and Strain Imaging


Left atrial function predicts new-onset atrial fibrillation after aortic valve replacement independently from atrial enlargement

Event: ESC Congress 2017

Topic: Ventricular evaluation

Session: Diastolic function and left atrial function


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb